Clinical Trial
doi: 10.1007/BF00262630.
Orgotein (superoxide dismutase): a drug for the amelioration of radiation-induced side effects. A double-blind, placebo-controlled study in patients with bladder tumours
- PMID: 105443
- DOI: 10.1007/BF00262630
Item in Clipboard
Clinical Trial
Orgotein (superoxide dismutase): a drug for the amelioration of radiation-induced side effects. A double-blind, placebo-controlled study in patients with bladder tumours
Urol Res.
1978.
Abstract
Orgotein, the drug version of Cu-Zn superoxide dismutases is a new and safe anti-inflammatory agent. Animal experiments have shown that it does not interfere with the tumourolytic effects of radiation or chemotherapy. A double-blind, placebo-controlled study has demonstrated that orgotein injected after each daily irradiation session can be used safely and effectively to ameliorate or prevent the side effects due to high-energy radiation therapy (8,400 or 6,400 rads) of bladder tumours. Orgotein significantly reduced the signs and symptoms both in the bladder and the bowel, indicating that it provides a therapeutic regimen for control of these side effects, which to date could only be treated symptomatically.
Similar articles
-
Orgotein efficacy in ameliorating side effects due to radiation therapy. I. Double-blind, placebo-controlled trial in patients with bladder tumors.Curr Ther Res Clin Exp. 1976 Feb;19(2):198-211. Curr Ther Res Clin Exp. 1976. PMID: 813958 Clinical Trial. No abstract available.
-
Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect.Acta Oncol. 1987;26(2):101-4. doi: 10.3109/02841868709091748. Acta Oncol. 1987. PMID: 2955799 Clinical Trial.
-
Prevention of radioinduced cystitis by orgotein: a randomized study.Anticancer Res. 1996 Jul-Aug;16(4A):2025-8. Anticancer Res. 1996. PMID: 8712737 Clinical Trial.
-
Radiation Induced Cystitis and Proctitis - Prediction, Assessment and Management.Asian Pac J Cancer Prev. 2015;16(14):5589-94. doi: 10.7314/apjcp.2015.16.14.5589. Asian Pac J Cancer Prev. 2015. PMID: 26320421 Review.
-
[Non-surgical treatment of acute and late radiation proctitis].Rev Med Suisse. 2005 Jan 19;1(3):228, 230, 232-5. Rev Med Suisse. 2005. PMID: 15770817 Review. French.
Cited by
-
A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.Transl Oncol. 2018 Jun;11(3):771-778. doi: 10.1016/j.tranon.2018.03.014. Epub 2018 Apr 23. Transl Oncol. 2018. PMID: 29698934 Free PMC article. Review.
-
Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis.Cochrane Database Syst Rev. 2016 Apr 25;4(4):CD003455. doi: 10.1002/14651858.CD003455.pub2. Cochrane Database Syst Rev. 2016. PMID: 27111831 Free PMC article.
-
Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action.Pharm Res. 2013 Nov;30(11):2718-28. doi: 10.1007/s11095-013-1113-5. Epub 2013 Jun 21. Pharm Res. 2013. PMID: 23793992 Review.
-
On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.Br J Pharmacol. 2003 Oct;140(3):445-60. doi: 10.1038/sj.bjp.0705430. Br J Pharmacol. 2003. PMID: 14522841 Free PMC article. Review.
-
The past, present, and future of enzyme-based therapies.Drug Discov Today. 2022 Jan;27(1):117-133. doi: 10.1016/j.drudis.2021.09.004. Epub 2021 Sep 16. Drug Discov Today. 2022. PMID: 34537332 Free PMC article. Review.